

Last week, HHS and the @US_FDA commended @DEAHQ's issuance of two Notices of Intent to begin the temporary scheduling process for certain kratom-related substances. This action is part of the Trump Administration's broader effort to combat the opioid epidemic, end addiction, crack down on deceptive products that threaten public health, and protect American families from dangerous synthetic drugs.









